open access

Vol 77, No 6 (2009)
EDITORIAL
Published online: 2009-11-30
Submitted: 2013-02-22
Get Citation

Management of COPD by chest physicians in Poland

Dorota Górecka, Jan Zieliński
Pneumonol Alergol Pol 2009;77(6):497-499.

open access

Vol 77, No 6 (2009)
EDITORIAL
Published online: 2009-11-30
Submitted: 2013-02-22

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Management of COPD by chest physicians in Poland

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 6 (2009)

Pages

497-499

Published online

2009-11-30

Bibliographic record

Pneumonol Alergol Pol 2009;77(6):497-499.

Authors

Dorota Górecka
Jan Zieliński

References (20)
  1. Mejza F, Niżankowska-Mogilnicka E, Kurzawa R, et al. Charakterystyka ambulatoryjnej opieki specjalistycznej nad chorymi na przewlekłą obturacyjną chorobę płuc w sce — wyniki badania KOMPAS. Pneumonol Alergol Pol. 2009; 77: 507–516.
  2. Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009; 374(9691): 721–732.
  3. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004; 23(6): 932–946.
  4. Rozpoznawanie i leczenie przewlekłej obturacyjnej choroby płuc. Wytyczne Światowej Inicjatywy Zwalczania Przewlekłej Obturacyjnej Choroby Płuc (GOLD 2006). Med Prakt. 2007; 2: 77–102.
  5. Zalecenia skiego Towarzystwa Ftizjopneumonologicznego rozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc. Pneumonol Alergol Pol. 2004; 72(supl. 1): 1–28.
  6. Chronic Obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004; 59(supl. 1): i1–i132.
  7. Executive summary. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease 2003. Canad Respir J. 2003; 10(supl. A): 1A–65A.
  8. Jackevicius CA, Chapman KR. Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey. Ann Pharmacother. 1997; 31(2): 160–164.
  9. Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respir J. 2009; 34(1): 13–16.
  10. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002; 166(5): 675–679.
  11. Petty TL, Doherty DE. NLHEP. Roots, mission, future directions. Respir Care. 2004; 49: 678–683.
  12. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%. Chest. 2007; 131(2): 349–355.
  13. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63(12): 1046–1051.
  14. Buist A, McBurnie M, Vollmer W, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. The Lancet. 2007; 370(9589): 741–750.
  15. Menezes AM, Perez-Padilla R, Jardim JR, et al. PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005; 366(9500): 1875–1881.
  16. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005; 60(10): 842–847.
  17. Bednarek M, Maciejewski J, Woźniak M, et al. Prevalence, severity, and under-diagnosis of COPD in primary care setting. Thorax. 2008; 63: 73–81.
  18. Miller MR, Pedersen OF, Pellegrino R, et al. Debating the definition of airflow obstruction: time to move on? Eur Respir J. 2009; 34(3): 527–528.
  19. Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J. 2009; 34(3): 588–597.
  20. Cerveri I, Corsico AG, Accordini S, et al. What defines airflow obstruction in asthma? Eur Respir J. 2009; 34(3): 568–573.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl